Kyntra Bio, Inc. (KYNB)

6.99 -0.11 (-1.55%) USD  |  NASDAQ  |  Sep 18, 16:00
6.99 0.00 (0.00%) After-Hours: 20:00
More

Kyntra Bio Revenue Estimates for Next Quarter

Revenue Estimates for Next Quarter Chart

View Revenue Estimates for Next Quarter for KYNB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Quarter Chart
Start Trial

Historical Revenue Estimates for Next Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
September 17, 2026 --
September 01, 2026 --
August 31, 2026 --
August 14, 2026 --
July 06, 2026 --
May 12, 2026 --
March 17, 2026 --
March 16, 2026 --
September 24, 2025 --
August 12, 2025 --
August 07, 2025 --
May 13, 2025 --
April 01, 2025 --
Date Value
March 18, 2025 --
November 13, 2024 --
August 09, 2024 --
August 07, 2024 --
July 31, 2024 --
July 17, 2024 --
June 26, 2024 --
June 03, 2024 --
May 24, 2024 --
May 18, 2024 --
May 07, 2024 --
April 18, 2024 --
April 03, 2024 --

Revenue Estimates for Next Quarter Range, Past 5 Years

View Revenue Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Quarter Benchmarks

View Revenue Estimates for Next Quarter Benchmarks
Start Trial
Vericel Corp. Upgrade
Capricor Therapeutics, Inc. Upgrade
ARS Pharmaceuticals, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade

Revenue Estimates for Next Quarter Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade